Pharmaceutical Analysis & Statistics, August 2014 (p100)

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: therapeutics, drug, cancer, more »

2971-3010 of about 24 000 reports

Purchase Reports From Reputable Market Research Publishers

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: The Kenyan pharmaceuticals and healthcare industry presents significant revenue earning opportunities for drug firms . Growth in the segment will be boosted by strong demographics, increased ...

  • Industries : Drug and Medication
  • Countries : Kenya
Mexico Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Building on rapid expansion over the past five years, Latin America's pharmaceutical industry will record stronger medium-term growth, driven by the introduction of new products for the region's ...

  • Industries : Generic Drug
  • Countries : Mexico
Algeria Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Algeria Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Algeria is currently a high-risk industry for multinational drugmakers because of the combination of regional political uncertainty and state interference in its business environment. The country's ...

  • Industries : Pharmaceutical
  • Countries : Algeria
Australia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Australia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Australian prospects for multinational drugmakers are mixed. In the first quarter of the year it was announced that eight medicines would not be included in the country's Pharmaceutical Benefits ...

  • Industries : Drug and Medication
  • Countries : Australia
Croatia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Croatia’s pharmaceutical industry appears relatively stable, recording 0.1% growth in 2010 – a year in which economic challenges were sizeable. Compared with its south eastern European neighbours, ...

  • Industries : Pharmaceutical
  • Countries : Croatia
Kazakhstan Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Kazakhstan Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Kazakhstan continues to stand out among the pharmaceutical industry s of Central Asia in terms of openness to foreign investment in the pharmaceutical market ...

  • Industries : Drug and Medication
  • Countries : Kazakhstan
Malaysia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Malaysia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The Malaysian pharmaceutical industry is relatively underdeveloped by international standards, with low per capita revenues (US Dollar 63 in 2011) constrained ...

  • Industries : Drug and Medication
  • Countries : Malaysia
Kuwait Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Kuwait Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Kuwait is in the middle of a large infrastructure expansion project that will increase access to healthcare and opportunities for drugmakers and healthcare ...

  • Industries : Generic Drug
  • Countries : Kuwait
Qatar Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Qatar Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Unlike other countries in the Middle East that have focused on encouraging pharmaceutical industry players to establish manufacturing facilities, Qatar’s ...

  • Industries : Drug and Medication
  • Countries : Qatar
United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014

United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The UAE is one of the more developed markets in the Middle East and has a strong existing healthcare infrastructure. As the UAE is aiming to introduce comprehensive ...

  • Industries : Drug and Medication
  • Countries : United Arab Emirates
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: A year has passed since the EU/IMF/ECB’s rescue package was approved, and the obligations that form part of the economic adjustment programme have had, and ...

  • Industries : Generic Drug
  • Countries : Portugal
Sri Lanka Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Sri Lanka Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Although Sri Lanka is an emerging pharmaceutical industry, it boasts relatively welldeveloped healthcare infrastructure and coverage. However, Sri Lanka’s low per capita spending on medicines ...

  • Industries : Pharmaceutical
  • Countries : Sri Lanka
South Africa Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

South Africa Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Improvements in the drug approvals process and a drug pricing system indicate that regulatory conditions in South Africa have improved significantly in recent years. However, the government’s ...

  • Industries : Drug and Medication
  • Countries : South Africa
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: In response to the expected passage of key drug policy reforms in the Czech Republic, BMI has cut its projections for pharmaceutical industry growth in 2012 to 0.0%, with the prospects of lowe ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Despite a more positive economic outlook, Lithuania is still considered one of the less attractive pharmaceutical industry s within Central and Eastern Europe (CEE). Factors such as difficult ...

  • Industries : Pharmaceutical
  • Countries : Lithuania
Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Our view that Greece's pharmaceutical industry is set for a decade of decline remains firmly in play. The list of challenges is sizeable: the combination of price erosion mechanisms; rapid generic ...

  • Industries : Drug and Medication
  • Countries : Greece
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The short-term outlook for the Serbian pharmaceutical industry will continue to be clouded by corruption, debts accrued by the country’s health insurance ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Slovakia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Slovakia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Despite the formation of new government in Slovakia, our contractionary outlook for the pharmaceutical industry has been maintained as key drug policy reforms ...

  • Industries : Prescription Drug
  • Countries : Slovakia (slovak Republic)
Ghana Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Ghana Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Ghana is one of the least attractive regional industry s in the Middle East and Africa (MEA), judging by our proprietary MEA Business Environment Ratings (BER) matrix. However, the country's ...

  • Industries : Drug and Medication
  • Countries : Ghana
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Full-year trade data for 2011 and Q112 has confirmed that Moldova’s pharmaceutical industry has returned to more normal growth. However, with regional economic ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: We believe the pharmaceuticals and healthcare segment may be targeted by the government's 2011 cost-containment efforts following the successful implementation of austerity measures in 2010. ...

  • Industries : Drug and Medication
  • Countries : Spain
Vietnam Pharmaceuticals and Healthcare Industry Update Quarter 3 2010

Vietnam Pharmaceuticals and Healthcare Industry Update Quarter 3 2010

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

In our Asia Pacific Business Environment Ratings (BER) matrix for Q310, Vietnam remains ranked 13th, out of 16 key regional industry s, which now include Cambodia. Despite a marginally improved score, ...

  • Industries : Pharmaceutical
  • Countries : Vietnam
Morocco Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Morocco Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Unlike many states in the Middle East and North Africa (MENA) region, Morocco does not have extensive natural oil and gas reserves. Consequently, the state's finances are stretched and there ...

  • Industries : Drug and Medication
  • Countries : Morocco
Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The government’s aim to create proper universal healthcare coverage is unlikely to be realised in the short term but would create investors’ interest in ...

  • Industries : Drug and Medication
  • Countries : Indonesia
Norway Pharmaceuticals and Healthcare Report Q3 2014

Norway Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: An ageing population and the subsequent increased consumption of high-value prescription medicines for the treatment of long-term illnesses will result in rising ...

  • Industries : Prescription Drug
  • Countries : Norway
Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: President Hugo Chavez's distortive economic policies are increasingly damaging Venezuela's attractiveness to pharmaceutical companies . The government's latest measure, which extends price controls ...

  • Industries : Drug and Medication
  • Countries : Venezuela
Chile Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Chile Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Chile’s intellectual property (IP) regime continues to be a cause of concern for the manufacturers of innovative pharmaceuticals, with the country listed ...

  • Industries : Drug and Medication
  • Countries : Chile
United States Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

United States Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The US pharmaceutical industry is entering a period of relative stagnation. Patent expiries, fewer insured patients and greater use of rebates and discounts ...

  • Industries : Drug and Medication
  • Countries : United States
Ireland Pharmaceuticals and Healthcare Report Q3 2014

Ireland Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We anticipate further cuts to healthcare spending to come in the coming months, in the wake of an EU Commission report citing public healthcare expenditure in ...

  • Industries : Prescription Drug
  • Countries : Ireland
Israel Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Israel Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Israel’s innovative pharmaceutical market continues to emerge from its strong generic drugs heritage. While most multinationals do not have a direct discovery ...

  • Industries : Drug and Medication
  • Countries : Israel
About 57 000 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry in Ethiopia

  • Prevalence and Antimicrobial Susceptibility Patterns of Shigella...
  • September 2014
    7 pages
  • Drug And Medica...  

  • Ethiopia  

View report >

Therapy Markets In The Us

September 2014

Drug Industry In The Us

September 2014

Pathology Description

September 2014

About 500 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.